Logiscreen

Organogenesis Holdings Inc - Class A

$0.90
Market Cap 116.12M
ROE -44.7%
Gross Margin 45.9%
Debt/Equity 0.5
Current Ratio 3.5
Revenue QoQ -56.7%
EPS QoQ 6.7%
F-Score 1

About

Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.

Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-16.50
vs median 37.08
P/B
1.26
vs median 2.65
ROE
-0.07
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics